PARI press portal

Press release


Starnberg, 30 March 2023

PARI receives the Plus X Award for its VELOX® mobile inhalation device

The PLUS X Award is awarded to PARI again in 2023. The expert jury of the world’s largest innovation prize has bestowed its seal of approval on the VELOX® for its outstanding quality, its design, ease of use and functionality.

PARI receives the Plus X Award for its VELOX® mobile inhalation device

The Plus X Award recognises and rewards international brands in the fields of technology, sport and lifestyle for their innovative products. Special attention is given to new and innovative technologies, exceptional design and intelligent control concepts. The seal of approval is awarded by an independent expert jury from a range of industries.

The VELOX® is a mobile inhalation device with innovative vibrating membrane technology. Made for people with acute or chronic airway diseases, the VELOX® combines many product benefits in one. These include fast and efficient inhalation, low noise operation and the chance of caring for patients to get the therapy they need for their airways on the move.

“We are proud of receiving this award again”, states Arne W. Dirks, CEO of the PARI Group. “It highlights the patient focus of our product portfolio which is a cornerstone of our products from the very first development stage.” At PARI the focus is on the premium quality, innovation and enhanced development of our products to improve the lives of those affected by respiratory diseases and those who care for them.

Back to the press portal

Your contact to us

Your contact to us

Any questions? Give us a call:
+49 (0) 8151 279 - 279
Or send us an E-Mail:

Postal address:
Moosstraße 3
82319 Starnberg, Germany


About PARI

As a manufacturer of medical devices with a focus on inhalation devices, PARI is the market leader in Germany, having established itself over decades as a trusted brand among doctors, pharmacies and patients, while its success in the cystic fibrosis segment has positioned the company as world market leader.

PARI was founded in Wuppertal in 1906 and now has its headquarters in Starnberg. Always an independent and privately owned company, the PARI group is under the umbrella of PARI Medical Holding, with the CEO Arne Dirks and is organized into several subsidiaries.

  • PARI GmbH (Starnberg), Jürgen Müller
  • PARI Pharma GmbH (Gräfelfing, Gilching), Dr. Stefan Seemann
  • PARItec GmbH (Weilheim), Jürgen Müller
  • PARI Respiratory Equipment Inc. (PRE), Richmond (Virginia), Geoff Hunziker

In addition, there are international branch offices and a worldwide distribution network.

With a workforce of about 600 and a management team that has been stable for many years, the company can look back on the history of more than 100 years in business. It is where tradition and innovation meet to deliver well thought-out and effective product lines with an excellent reputation. Clinically proven, tried and tested nebulisers and inhalation devices made in Germany with affirmed performance have been used in countless pivotal studies and have won over medical specialists and users for decades.

Among the most well-known products are the PARI BOY®, which is synonymous with inhalation therapy and, first introduced more than 50 years ago, is now on its 8th generation. And the eFlow®rapid nebuliser based on vibrating membrane technology that works hand-in-hand with countless drug-specific application options as a new treatment option in various respiratory diseases.


Your contact for media relations: 

Public Relations
Moosstrasse 3, 82139 Starnberg
Tel.: 08151 279 0  
Fax: 08151 279 6119